GlassScriptPhysician profile
Jarrett Morgan
NPI 1144615972
$387.12
in general payments reported to CMS, 2019-2025
11 companies · $49.72 in 2025
The $49.72 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $59.53 · 2021: $123 · 2022: $87.44 · 2023: $13.78 · 2024: $53.55 · 2025: $49.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $117.74 | 2020-2025 | |
| Novo Nordisk INC | $84.43 | 2022-2024 | Wegovy |
| Endo Pharmaceuticals INC. | $34.86 | 2020-2021 | |
| Abbvie INC. | $34.32 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $26.89 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.06 | 2021 | |
| Merck Sharp & Dohme LLC | $17.52 | 2022 | |
| Lilly USA, LLC | $14.81 | 2025 | Mounjaro, Zepbound |
| Alnylam Pharmaceuticals INC. | $13.51 | 2025 | Givlaari |
| E.R. Squibb & Sons, L.L.C. | $12.88 | 2021 | |
| Vivus LLC | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrett Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.